- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.04. | Ipsen signs $1.8bn RNA drug alliance with Skyhawk | ||
| 22.04. | CSL Vifor offers campaign to mollify EC in antitrust probe | ||
| 22.04. | Astellas' generic Myrbetriq defence knocked back again | ||
| 19.04. | Hyundai Bio plans trials of antiviral for dengue fever | ||
| 19.04. | Experimental AI predicts whether cancer drugs will work | ||
| 19.04. | Cerevel Parkinson's data adds lustre to AbbVie acquisition | ||
| 19.04. | FDA clears Roche's Alecensa for adjuvant use in NSCLC | ||
| 19.04. | Metsera lands with $290m to take on obesity giants | ||
| 18.04. | Heart disease risk 'calculator' could save lives | ||
| 18.04. | FDA fast-tracks AskBio's heart failure gene therapy | ||
| 18.04. | Ireland sets out its stall as Europe's medtech hotspot | ||
| 18.04. | Brexit is 'driving NHS medicines shortages,' says report | ||
| 17.04. | Sage drops dalzanemdor for Parkinson's after trial flop | ||
| 17.04. | Trials set up filing for Lilly's tirzepatide in sleep apnoea | ||
| 17.04. | Telehealth firm Cerebral faces $7m FTC fine over privacy | ||
| 17.04. | MaaT microbiota drug shows survival advantage in GvHD | ||
| 17.04. | GSK reveals data on novel gonorrhoea drug gepotidacin | ||
| 17.04. | Intra-Cellular sets up $500m offer on Caplyta depression win | ||
| 16.04. | GSK trails after Pfizer in 5-in-1 meningococcal vaccine race | ||
| 16.04. | Boehringer says R&D pipeline is the best in its long history | ||
| 16.04. | 'Stiffness' of cells could give early warning of cancer | ||
| 16.04. | Smart sensor cleared for use with AZ asthma, COPD inhalers | ||
| 15.04. | Activist hedge fund seeks big shake-up at Novavax | ||
| 15.04. | Regeneron launches $500m venture capital arm | ||
| 15.04. | Healthware re-launches as Eversana Intouch full service affiliate |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
